C4 Therapeutics

CCCC · NASDAQ

$3.16+$0.27 (+9.34%)TodayMarket closed ·
Prev close $2.89

Who owns CCCC

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 58.5% of CCCC’s shares.

  • Sirenia Capital Management LP8.4%
  • Morgan Stanley & Co. LLC8.0%
  • RA Capital Management, LP7.2%
  • Lynx1 Capital Advisors LLC6.6%
  • Next 6 largest institutions28.2%
  • All other shareholders41.5%
Top institutional holders of CCCC
HolderShares% of shares
Sirenia Capital Management LP9.34M8.44%
Morgan Stanley & Co. LLC8.85M8.01%
RA Capital Management, LP8.00M7.24%
Lynx1 Capital Advisors LLC7.33M6.63%
Squadron Capital Management LLC7.20M6.51%
BlackRock Institutional Trust Company, N.A.7.18M6.50%
J.P. Morgan Securities LLC4.70M4.25%
Vanguard Capital Management, LLC4.42M4.00%
Citadel Advisors LLC4.19M3.79%
Wasatch Global Investors Inc3.52M3.19%

Largest mutual fund holders

Top mutual fund holders of CCCC
HolderShares% of shares
Vanguard Total Stock Market Index Fund3.26M2.95%
Candriam Equities L Oncology2.76M2.50%
iShares Russell 2000 ETF2.58M2.34%
Wasatch Ultra Growth Fund2.50M2.26%
Biotech Growth Trust PLC1.10M1.00%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of CCCC in the last 6 months.

Latest CCCC insider transactions
InsiderTypeSharesValue
Anderson Kenneth CarlAward3.66K$11.50K
GROGAN DONNA ROYAward4.62K$14.50K
Adams KendraTax withholding2.77K$9.41K
Adams KendraOption exercise6.25K—
REYNO LEONARDTax withholding7.40K$30.03K
REYNO LEONARDOption exercise15.32K—
GROGAN DONNA ROYAward3.34K$14.50K
Anderson Kenneth CarlAward2.65K$11.50K
Koppikar UtpalAward62.00K—
Anderson Kenneth CarlAward62.00K—

Short interest

Settled Sep 30, 2026

Shares short
40.40M
Days to cover
17.65
% of shares outstanding
36.53%
Average daily volume
2.29M
Change since last report
+0.5%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.